Cleared Abbreviated

K042473 - COBE ANGEL WHOLE BLOOD SEPARATION SYSTEM

K042473 is an FDA 510(k) clearance for COBE ANGEL WHOLE BLOOD SEPARATION SYSTEM, manufactured by Cobe Cardiovascular, Inc.. The device is a Class 1 Hematology device with product code JQC cleared through the Abbreviated 510(k) pathway after a 67-day FDA review.

K042473 · Cobe Cardiovascular, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2004
Decision
67d
Days
Class 1
Risk

K042473 is an FDA 510(k) clearance for the COBE ANGEL WHOLE BLOOD SEPARATION SYSTEM. Classified as Centrifuges (micro, Ultra, Refrigerated) For Clinical Use (product code JQC), Class I - General Controls.

Submitted by Cobe Cardiovascular, Inc. (Arvada, US). The FDA issued a Cleared decision on November 19, 2004 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.2050 - the FDA hematology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Cobe Cardiovascular, Inc. devices

FDA 510(k) Submission Details - K042473

510(k) Number K042473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2004
Decision Date November 19, 2004
Days to Decision 67 days
Submission Type Abbreviated
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 113d · This submission: 67d
Pathway characteristics
Standards-based clearance path.

JQC Device Classification - Class 1, General Controls

Product Code JQC Centrifuges (micro, Ultra, Refrigerated) For Clinical Use
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.2050
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JQC Centrifuges (micro, Ultra, Refrigerated) For Clinical Use

All 15
Devices cleared under the same product code (JQC) and FDA review panel - the closest regulatory comparables to K042473.
PureBMC SupraPhysiologic Concentrating System 30 mL System, PureBMC SupraPhysiologic Concentrating System 60 mL System, PureBMC SupraPhysiologic Concentrating System 120 mL System
K183205 · Emcyte Corporation · May 2019
MARROWSTIM CONCENTRATION KIT AND MARROWSTIM MINI CONCENTRATION KIT
K071934 · Biomet Manufacturing Corp · Oct 2007
GPS PLATELET SEPARATION KIT WITH ANTICOAGULANT ACD-A
K030555 · Biomet, Inc. · Apr 2003
MAGELLAN AUTOLOGUS PLATELET SEPARATOR, MAG100, MAGELLAN AUTOLOGOUS PLATELET SEPARATOR DEISPOSABLE KIT, MKT300
K021902 · Medtronic Vascular · Aug 2002
3I MODEL(S)7426 AND 7427 CELSEP CENTRIFUGE SYSTEM
K994148 · Implant Innovations, Inc. · Feb 2000
DU PONT SORVALL CENTRIFUGES (RAPIDSPIN R)
K860747 · E.I. Dupont DE Nemours & Co., Inc. · Apr 1986